Atorvastatin Calcium
Product Images NDC 68151-1013

5 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68151-1013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (68151 1013)

Label Image (68151 1013)
Atorvastatin Calcium 20 mg tablet label from Carilion Materials Management, manufactured by Apotex. The label shows the lot number KP1563, expiration date 07/14, and includes a barcode with product code 0000001013. It is marked for prescription use only (Rx only).*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium showing the molecular arrangement of its components including the calcium ion (Ca 2+) and organic moieties. The diagram illustrates the detailed atomic connectivity relevant to the active pharmaceutical ingredient atorvastatin calcium.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing cumulative incidence (%) over time (years) between Atorvastatin and Placebo groups. The graph shows two curves: a solid line for Atorvastatin and a dashed line for Placebo, with Atorvastatin having a lower cumulative incidence. Additional statistics including a hazard ratio and p-value are included on the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line chart comparing the cumulative hazard percentage over time (years) between placebo and atorvastatin groups. The x-axis represents years from 0 to 5, and the y-axis shows cumulative hazard percentage up to 15%. The graph shows lower cumulative hazard with atorvastatin versus placebo over approximately four years of follow-up.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5 years), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). The graph includes a hazard ratio (HR 0.78) with confidence interval and a p-value (P=0.0002).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.